A retrospective study investigating radiation dosimetry of 177Lu-PSMA imaging and therapy in metastatic castration-resistant prostate cancer

Trial Profile

A retrospective study investigating radiation dosimetry of 177Lu-PSMA imaging and therapy in metastatic castration-resistant prostate cancer

Completed
Phase of Trial: Phase I

Latest Information Update: 19 May 2017

At a glance

  • Drugs PSMA 617 (Primary)
  • Indications Prostate cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 19 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top